{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:45:37Z","timestamp":1789623937581,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T00:00:00Z","timestamp":1435536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T00:00:00Z","timestamp":1435536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,4,14]]},"DOI":"10.1038\/onc.2015.243","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T10:05:01Z","timestamp":1435572301000},"page":"1996-2002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma"],"prefix":"10.1038","volume":"35","author":[{"given":"A","family":"Napolitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E G","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Lapid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kanodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H I","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,29]]},"reference":[{"key":"BFonc2015243_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012; 227: 44\u201358.","journal-title":"J Cell Physiol"},{"key":"BFonc2015243_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","volume":"19","author":"SJ Henley","year":"2013","unstructured":"Henley SJ, Larson TC, Wu M, Antao VC, Lewis M, Pinheiro GA et al. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003\u20132008. Int J Occup Environ Health 2013; 19: 1\u201310.","journal-title":"Int J Occup Environ Health"},{"key":"BFonc2015243_CR3","unstructured":"Networks UC Mesothelioma (C) European age standardised incidence rates, 2008\u20132010."},{"key":"BFonc2015243_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","volume":"18","author":"M Carbone","year":"2012","unstructured":"Carbone M, Yang H . Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res 2012; 18: 598\u2013604.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015243_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","volume":"121","author":"R Kim","year":"2007","unstructured":"Kim R, Emi M, Tanabe K . Cancer immunoediting from immune surveillance to immune escape. Immunology 2007; 121: 1\u201314.","journal-title":"Immunology"},{"key":"BFonc2015243_CR6","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL . The tumor microenvironment and its role in promoting tumor growth. Oncogene 2008; 27: 5904\u20135912.","journal-title":"Oncogene"},{"key":"BFonc2015243_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/path.4133","volume":"229","author":"A Mantovani","year":"2013","unstructured":"Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M . Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229: 176\u2013185.","journal-title":"J Pathol"},{"key":"BFonc2015243_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW . Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014; 41: 49\u201361.","journal-title":"Immunity"},{"key":"BFonc2015243_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/jcmm.12109","volume":"17","author":"F Pantano","year":"2013","unstructured":"Pantano F, Berti P, Guida FM, Perrone G, Vincenzi B, Amato MM et al. The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients. J Cell Mol Med 2013; 17: 1415\u20131421.","journal-title":"J Cell Mol Med"},{"key":"BFonc2015243_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1757-2215-7-19","volume":"7","author":"M Zhang","year":"2014","unstructured":"Zhang M, He Y, Sun X, Li Q, Wang W, Zhao A et al. A high M1\/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. J Ovarian Res 2014; 7: 19.","journal-title":"J Ovarian Res"},{"key":"BFonc2015243_CR11","doi-asserted-by":"publisher","first-page":"e106742","DOI":"10.1371\/journal.pone.0106742","volume":"9","author":"R Cornelissen","year":"2014","unstructured":"Cornelissen R, Lievense LA, Maat AP, Hendriks RW, Hoogsteden HC, Bogers AJ et al. Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma. PloS One 2014; 9: e106742.","journal-title":"PloS One"},{"key":"BFonc2015243_CR12","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1002\/cncr.26143","volume":"117","author":"BM Burt","year":"2011","unstructured":"Burt BM, Rodig SJ, Tilleman TR, Elbardissi AW, Bueno R, Sugarbaker DJ . Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Cancer 2011; 117: 5234\u20135244.","journal-title":"Cancer"},{"key":"BFonc2015243_CR13","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011; 43: 1022\u20131025.","journal-title":"Nat Genet"},{"key":"BFonc2015243_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1479-5876-10-179","volume":"10","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 2012; 10: 179.","journal-title":"J Transl Med"},{"key":"BFonc2015243_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G . BAP1 and cancer. Nat Rev Cancer 2013; 13: 153\u2013159.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015243_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/carcin\/bgu227","volume":"36","author":"F Baumann","year":"2015","unstructured":"Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis 2015; 36: 76\u201381.","journal-title":"Carcinogenesis"},{"key":"BFonc2015243_CR17","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.6283630","volume":"216","author":"P Sebastien","year":"1982","unstructured":"Sebastien P, Bignon J, Martin M . Indoor airborne asbestos pollution: from the ceiling and the floor. Science 1982; 216: 1410\u20131412.","journal-title":"Science"},{"key":"BFonc2015243_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/JTO.0000000000000506","volume":"10","author":"F Baumann","year":"2015","unstructured":"Baumann F, Buck BJ, Metcalf RV, McLaurin BT, Merkler D, Carbone M . The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from Southern Nevada. J Thorac Oncol 2015; 10: 731\u2013737.","journal-title":"J Thorac Oncol"},{"key":"BFonc2015243_CR19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 2012; 337: 1541\u20131546.","journal-title":"Science"},{"key":"BFonc2015243_CR20","first-page":"1069","volume":"105","author":"JM Marsella","year":"1997","unstructured":"Marsella JM, Liu BL, Vaslet CA, Kane AB . Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers. Environ Health Perspect 1997; 105: 1069\u20131072.","journal-title":"Environ Health Perspect"},{"key":"BFonc2015243_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ijc.2910520609","volume":"52","author":"MR Davis","year":"1992","unstructured":"Davis MR, Manning LS, Whitaker D, Garlepp MJ, Robinson BW . Establishment of a murine model of malignant mesothelioma. Int J Cancer 1992; 52: 881\u2013886.","journal-title":"Int J Cancer"},{"key":"BFonc2015243_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011; 43: 668\u2013672.","journal-title":"Nat Genet"},{"key":"BFonc2015243_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H et al. High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol 2015; 10: 565\u2013576.","journal-title":"J Thorac Oncol"},{"key":"BFonc2015243_CR24","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","volume":"103","author":"Y Yoshikawa","year":"2012","unstructured":"Yoshikawa Y, Sato A, Tsujimura T, Emi M, Morinaga T, Fukuoka K et al. Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma. Cancer Sci 2012; 103: 868\u2013874.","journal-title":"Cancer Sci"},{"key":"BFonc2015243_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","volume":"20","author":"A de Reynies","year":"2014","unstructured":"de Reynies A, Jaurand MC, Renier A, Couchy G, Hysi I, Elarouci N et al. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clin Cancer Res 2014; 20: 1323\u20131334.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015243_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","volume":"10","author":"M Lo Iacono","year":"2015","unstructured":"Lo Iacono M, Monica V, Righi L, Grosso F, Libener R, Vatrano S et al. Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. J Thorac Oncol 2015; 10: 492\u2013499.","journal-title":"J Thorac Oncol"},{"key":"BFonc2015243_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","volume":"75","author":"G Guo","year":"2015","unstructured":"Guo G, Chmielecki J, Goparaju C, Heguy A, Dolgalev I, Carbone M et al. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res 2015; 75: 264\u2013269.","journal-title":"Cancer Res"},{"key":"BFonc2015243_CR28","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/JTO.0b013e31829e7ef9","volume":"8","author":"MG Zauderer","year":"2013","unstructured":"Zauderer MG, Bott M, McMillan R, Sima CS, Rusch V, Krug LM et al. Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations. J Thorac Oncol 2013; 8: 1430\u20131433.","journal-title":"J Thorac Oncol"},{"key":"BFonc2015243_CR29","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","volume":"74","author":"J Xu","year":"2014","unstructured":"Xu J, Kadariya Y, Cheung M, Pei J, Talarchek J, Sementino E et al. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma. Cancer Res 2014; 74: 4388\u20134397.","journal-title":"Cancer Res"},{"key":"BFonc2015243_CR30","doi-asserted-by":"publisher","first-page":"e18828","DOI":"10.1371\/journal.pone.0018828","volume":"6","author":"DA Altomare","year":"2011","unstructured":"Altomare DA, Menges CW, Xu J, Pei J, Zhang L, Tadevosyan A et al. Losses of both products of the Cdkn2a\/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. PloS One 2011; 6: e18828.","journal-title":"PloS One"},{"key":"BFonc2015243_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature08966","volume":"465","author":"JC Scheuermann","year":"2010","unstructured":"Scheuermann JC, de Ayala Alonso AG, Oktaba K, Ly-Hartig N, McGinty RK, Fraterman S et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 2010; 465: 243\u2013247.","journal-title":"Nature"},{"key":"BFonc2015243_CR32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","volume":"16","author":"DE Jensen","year":"1998","unstructured":"Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 1998; 16: 1097\u20131112.","journal-title":"Oncogene"},{"key":"BFonc2015243_CR33","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1128\/MCB.00396-10","volume":"30","author":"H Yu","year":"2010","unstructured":"Yu H, Mashtalir N, Daou S, Hammond-Martel I, Ross J, Sui G et al. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol 2010; 30: 5071\u20135085.","journal-title":"Mol Cell Biol"},{"key":"BFonc2015243_CR34","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1128\/MCB.01517-08","volume":"29","author":"S Misaghi","year":"2009","unstructured":"Misaghi S, Ottosen S, Izrael-Tomasevic A, Arnott D, Lamkanfi M, Lee J et al. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol Cell Biol 2009; 29: 2181\u20132192.","journal-title":"Mol Cell Biol"},{"key":"BFonc2015243_CR35","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1038\/ncomms6128","volume":"5","author":"HS Lee","year":"2014","unstructured":"Lee HS, Lee SA, Hur SK, Seo JW, Kwon J . Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis. Nat Commun 2014; 5: 5128.","journal-title":"Nat Commun"},{"key":"BFonc2015243_CR36","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1158\/0008-5472.CAN-14-0221","volume":"74","author":"R Zarrizi","year":"2014","unstructured":"Zarrizi R, Menard JA, Belting M, Massoumi R . Deubiquitination of gamma-tubulin by BAP1 prevents chromosome instability in breast cancer cells. Cancer Res 2014; 74: 6499\u20136508.","journal-title":"Cancer Res"},{"key":"BFonc2015243_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1073\/pnas.1309085110","volume":"111","author":"H Yu","year":"2014","unstructured":"Yu H, Pak H, Hammond-Martel I, Ghram M, Rodrigue A, Daou S et al. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc Natl Acad Sci USA 2014; 111: 285\u2013290.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015243_CR38","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","volume":"74","author":"IH Ismail","year":"2014","unstructured":"Ismail IH, Davidson R, Gagne JP, Xu ZZ, Poirier GG, Hendzel MJ . Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res 2014; 74: 4282\u20134294.","journal-title":"Cancer Res"},{"key":"BFonc2015243_CR39","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/ijc.28988","volume":"135","author":"C Cybulski","year":"2014","unstructured":"Cybulski C, Nazarali S, Narod SA . Multiple primary cancers as a guide to heritability. Int J Cancer 2014; 135: 1756\u20131763.","journal-title":"Int J Cancer"},{"key":"BFonc2015243_CR40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cell.2013.03.020","volume":"153","author":"A Lujambio","year":"2013","unstructured":"Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE et al. Non-cell-autonomous tumor suppression by p53. Cell 2013; 153: 449\u2013460.","journal-title":"Cell"},{"key":"BFonc2015243_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/019021400404528","volume":"26","author":"S Tanaka","year":"2000","unstructured":"Tanaka S, Choe N, Iwagaki A, Hemenway DR, Kagan E . Asbestos exposure induces MCP-1 secretion by pleural mesothelial cells. Exp Lung Res 2000; 26: 241\u2013255.","journal-title":"Exp Lung Res"},{"key":"BFonc2015243_CR42","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.4049\/jimmunol.159.8.3921","volume":"159","author":"PP Simeonova","year":"1997","unstructured":"Simeonova PP, Toriumi W, Kommineni C, Erkan M, Munson AE, Rom WN et al. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J Immunol 1997; 159: 3921\u20133928.","journal-title":"J Immunol"},{"key":"BFonc2015243_CR43","unstructured":"Occupational Safety & Health Administration. OSHA FactSheet: Asbestos 2014. http:\/\/www.osha.gov\/Publications\/OSHA3507.pdf."},{"key":"BFonc2015243_CR44","doi-asserted-by":"publisher","first-page":"14128","DOI":"10.1073\/pnas.0604544103","volume":"103","author":"B Kroczynska","year":"2006","unstructured":"Kroczynska B, Cutrone R, Bocchetta M, Yang H, Elmishad AG, Vacek P et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci USA 2006; 103: 14128\u201314133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015243_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12967-014-0301-3","volume":"12","author":"S Comertpay","year":"2014","unstructured":"Comertpay S, Pastorino S, Tanji M, Mezzapelle R, Strianese O, Napolitano A et al. Evaluation of clonal origin of malignant mesothelioma. J Transl Med 2014; 12: 301.","journal-title":"J Transl Med"},{"key":"BFonc2015243_CR46","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.ajpath.2013.07.029","volume":"183","author":"F Qi","year":"2013","unstructured":"Qi F, Okimoto G, Jube S, Napolitano A, Pass HI, Laczko R et al. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-alpha signaling. Am J Pathol 2013; 183: 1654\u20131666.","journal-title":"Am J Pathol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2015243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015243","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T21:13:58Z","timestamp":1691788438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2015243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,29]]},"references-count":46,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,4,14]]}},"alternative-id":["BFonc2015243"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.243","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,29]]},"assertion":[{"value":"14 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M Carbone has pending patent applications on BAP1 and provides consultation for mesothelioma expertise and diagnosis. The remaining authors declare no conflicts of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}